Recombinant factor VIIa - SmartZyme BioPharma

Drug Profile

Recombinant factor VIIa - SmartZyme BioPharma

Alternative Names: rFVIIa - SmartZyme BioPharma; SZ 7

Latest Information Update: 10 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator SmartZyme Biopharma
  • Class Blood coagulation factors; Coagulants; Recombinant proteins; Serine endopeptidases
  • Mechanism of Action Blood coagulation factor replacements; Factor-VII replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Haemorrhage

Most Recent Events

  • 05 Jul 2017 Early research in Haemorrhage in Israel (SmartZyme BioPharma pipeline, July 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top